Hyp mice exhibit increased renal catabolism of vitamin D metabolites by the C-24 oxidation pathway (1988. J. Clin. Invest. 81:461-465). To examine the regulatory influence of dietary phosphate on the renal vitamin D catabolic pathway in Hyp mice, we measured C-24 oxidation of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in renal mitochondria isolated from Hyp mice and normal littermates fed diets containing 0.03% (lowPi), 1% (control-Pi), and 1.6% (high-Pi) phosphate. In normal mice the low-Pi diet led to a rise in serum 1,25(OH)2D (22.2±1.8 to 48.1±6.8 pg/ml, P < 0.05) and no change in C-24 oxidation products (0.053±0.006 to 0.066±0.008 pmol/mg protein per min) when compared with the control diet. In Hyp mice the low-Pi diet elicited a fall in serum 1,25(OH)2D (21.9±1.2 to 8.0±0.2 pg/ml, P < 0.05) and a dramatic increase in C-24 oxidation products (0.120±0.017 to 0.526±0.053 pmol/mg protein per min, P < 0.05) when compared with the control diet. The high-Pi diet did not significantly alter serum levels of 1,25(OH)2D or C-24 oxidation products in normal mice. Hyp mice on the high-Pi diet experienced a rise in serum 1,25(0H-1D (21.9±1.2 to 40.4±7.3, P < 0.05) and a fall in C-24 oxidation products (0.120±0.017 to 0.043±0.007 pmol/ mg protein per min, P < 0.05). The present results demonstrate that the defect in C-24 oxidation of 1,25(0H)2D3 in Hyp mice is exacerbated by phosphate depletion and corrected by phosphate supplementation. The data suggest that the disorder in vitamin D metabolism in the mutant strain is secondary to the perturbation in phosphate homeostasis. (J. Clin. Invest. 1990Invest. . 85:1450Invest. -1455.) Hyp mouse-1,25-dihydroxyvitamin D3 * 1,24,25-trihydroxyvitamin D3 -C-24 oxidation -25-hydroxyvitamin D3-24-hydroxylase
Introduction
The murine hypophosphatemic (Hyp)' mutation, a homologue of X-linked hypophosphatemia in man, is a Mendelian disorder of phosphate homeostasis characterized by hypophosphatemia, rickets, and a specific impairment in renal brush border membrane phosphate transport (1, 2) . The demonstration of normal plasma concentrations of 1,25-dihydroxyvitamin D(1,25(OH)2D) in adult Hyp mice (3) and in patients with X-linked hypophosphatemia (4) , in the face of significant hypophosphatemia, suggested that the X-linked mutation also perturbs the regulation of renal vitamin D metabolism. Indeed, Hyp mice exhibit a blunted response to activators of renal 1,25(OH)2D3 synthesis when compared with normal littermates (3, (5) (6) (7) (8) (9) (10) , and also demonstrate increased renal catabolism of 1,25(OH)2D3 (11) and other vitamin D metabolites (12) . Studies in our laboratories have demonstrated that accelerated renal degradation of vitamin D metabolites in the mutant strain can be attributed to increased renal 25-hydroxyvitamin D3-24-hydroxylase (24-hydroxylase) activity, the first enzyme in the C-24 oxidation pathway, which converts the vitamin D hormone to 1,24,25-trihydroxyvitamin D3, a metabolite with reduced biological activity (11) .
The renal 25-hydroxyvitamin D3-l-hydroxylase response to dietary phosphate intake is physiologically inappropriate in Hyp mice when compared with normal littermates (9, 10) . Whereas phosphate restriction stimulates renal 1,25(OH)2D3 production in normal mice, the low-phosphate diet elicited an inhibition of vitamin D hormone synthesis in the mutant strain (9, 10) . In addition, it was also reported that whereas phosphate supplementation did not significantly alter 1,25(OH)2D3 production in normal mice, high-phosphate diets led to a marked increase in renal 1,25(OH)2D3 synthesis in the mutant strain (10) .
It is well established that both the synthetic (I-hydroxylase, 25-hydroxyvitamin D3-1-hydroxylase) and the catabolic (24-hydroxylase) enzymes for 1,25(OH)2D3 are expressed in mammalian kidney (13) . However, with the exception ofthose studies that examined renal 1,25(OH)2D3 synthesis in vitamin Dand calcium-deprived Hyp mice, where renal 24-hydroxylase activity was completely suppressed (5-7), and where the production of 1,24,25-trihydroxyvitamin D3 was monitored and not detected (14) , 1,25(OH)2D3 synthesis in the mutant strain has been quantitated in renal preparations capable of both the synthetic and catabolic pathways (8) (9) (10) . Accordingly, it is difficult to establish whether the net decrease in 1,25(OH)2D3 synthesis observed in phosphate-deprived Hyp mice (9, 10) is due to decreased synthesis or increased catabolism of the hormone. Similarly, the net increase in 1,25(OH)2D3 synthesis in the phosphate-supplemented Hyp mice (10) Table I . The low-Pi diet elicited a fall in serum phosphate, a drop in the urine phosphate/creatinine ratio, a small rise in serum calcium, and a marked increase in the urine calcium/creatinine ratio in both genotypes. In addition, both genotypes experienced a decrease in urinary cAMP excretion, relative to creatinine, in response to phosphate deprivation. The urine creatinine concentration (3.76±0.02 mM, mean±SEM, n = 47) was not influenced by either dietary phosphate or the Hyp mutation.
The effect of dietary phosphate deprivation on renal mitochondrial catabolism of 1,25(OH)2D3 in normal and Hyp mice is shown in Fig. 1 . In normal mice, the low-Pi diet had no effect on the rate of appearance of C-24 oxidation products (0.053±0.006 vs. 0.066±0.008 pmol/mg protein per min for control-Pi and low-Pi diets, respectively). In contrast, Hyp mice responded to dietary phosphate restriction with a marked increase in C-24 oxidation of I, 25 more pronounced on the low-Pi diet than on the control diet (Fig. 1 ).
The effect of phosphate restriction on the renal catabolism of 25-hydroxyvitamin D3 (25(OH)D3) in +/Y and Hyp mice is shown in Fig. 2 , and is similar to that seen for 1,25(OH)2D3 (Fig. 1), i.e., the low-Pi diet stimulates the catabolic pathway in mutant mice (0.594±0.109 vs. 1.993±0.451 pmol/mg protein per min for control-Pi and low-Pi diets, respectively), but has no effect in normal littermates (0.305±0.034 vs. 0.353±0.060 pmol/mg protein per min for control-Pi and low-Pi diets, respectively). Again, the genotype difference in the vitamin D catabolic pathway is significantly greater in mice fed the low-Pi diet. Table I summarizes the effects of phosphate supplementation on serum and urine parameters in normal and Hyp mice. In both genotypes, the high-Pi diet led to a significant rise in serum phosphate and to an increase in the urinary excretion of phosphate and cAMP relative to creatinine. Neither genotype experienced a change in serum calcium or urine calcium/creatinine excretion on the high-Pi diet (Table I) .
The high-Pi diet had no significant effect on the catabolism Fig. 4 B depicts the relationship between renal C-24 oxidation of 1,25(OH)2D3 and the serum phosphate concentration in normal and Hyp mice. At serum phosphate concentrations < 5 mg%, the renal catabolism of vitamin D hormone is higher in Hyp mice than in normal littermates.
Discussion
The present study demonstrates for the first time that the renal catabolism of the vitamin D hormone, 1,25(OH)2D3, as measured by the production of C-24 oxidation products, is markedly stimulated by phosphate deprivation and inhibited by phosphate supplementation in X-linked Hyp mice. In contrast to the mutant strain, 1,25(OH)2D3 catabolism does not appear to be modulated by dietary phosphate in normal mice. Our data also demonstrate that dietary phosphate deprivation lowers the serum concentration of 1,25(OH)2D in Hyp mice, while dietary phosphate supplementation increases the circulating hormone level. In normal mice, dietary phosphate supplementation has no effect on the circulating levels of 1,25(OH)2D, whereas phosphate deprivation is accompanied by an increase in serum 1,25(OH)2D as reported previously (3).
Our data suggest that the failure of Hyp mice to respond to dietary phosphate deprivation with increased serum levels of 1,25(OH)2D may be ascribed to the substantial increase in renal vitamin D hormone catabolism as well as to the reported decrease in 1,25(OH)2D3 synthesis (9, 10) observed in the mu- ( 19) . Since 24-hydroxylase is the first enzyme in the C-24 oxidation pathway, these results suggested, albeit indirectly, that the catabolic pathway is inhibited by phosphate deprivation and stimulated by phosphate supplementation. Studies in isolated renal mitochondria derived from phosphate-deprived normal mice and phosphate-supplemented Hyp mice led to similar conclusions; namely, that phosphate restriction inhibited 24-hydroxylase activity in normal mice and phosphate supplementation stimulated 24,25(OH)2D3 synthesis in Hyp mice (22) . However, these data are not compatible with those of the present study, in which we clearly demonstrate that in normal mice dietary phosphate intake does not have a significant effect on the degradation of vitamin D3 metabolites, whereas in Hyp mice the catabolic pathway is stimulated by phosphate restriction and inhibited by phosphate supplementation. Our results in normal mice are consistent with those of Serum Pi (mg %)
.9 8 9 metabolic clearance rate. In this study we demonstrate that the renal defect in 1,25(OH)2D3 catabolism in Hyp mice can be corrected by phosphate supplementation. These results suggest that the disorder in the regulation of renal vitamin D metabolism in the mutant strain is secondary to the perturbation in phosphate homeostasis. Although we have not directly investigated the effect of phosphate supplementation on the renal brush border membrane phosphate transport defect, it is clear from our in vivo data that the high-Pi diet did not normalize the fractional excretion index for phosphate in Hyp mice when compared with +/Y littermates (urine phosphate/urine creatinine/serum phosphate = 2.40 and 3.46 for phosphate-supplemented normals and mutant mice, respectively; derived from data in Table I ). In an earlier study we showed that 1,25(OH)2D3 treatment of Hyp mice also failed to correct the brush border membrane phosphate transport defect, although it improved phosphate homeostasis in Hyp mice by stimulating intestinal phosphate absorption (28) . Taken together, the data suggest that the primary defect in Hyp mice is a disorder in phosphate homeostasis, which most likely involves the renal brush border membrane phosphate transporter or a regulator thereof.
It is ofinterest that the low-Pi diet elicits a significant rise in serum calcium and a substantial hypercalciuric response in both genotypes, yet only the normal mice respond to phosphate deprivation with increased serum levels of 1,25(OH)2D. These data suggest that the calcemic and calciuric responses to phosphate deprivation are not dependent on the elevation in serum 1,25(OH)2D as was previously suggested (29) . Although the calciuric response may be ascribed to a fall in the circulating concentration of PTH, evidenced by the diet-induced fall in urinary cAMP, it is difficult to explain the increase in serum calcium by the same mechanism.
The present study provides a further rationale for the efficacy of combined therapy with oral phosphate and 1,25(OH)2D3 in the treatment of patients with X-linked hypophosphatemia (2, 4, 30) . Phosphate supplementation, which is necessary to stimulate bone mineralization in these patients, may also play an important role in the maintenance of the steady-state serum concentration of 1,25(OH)2D by reducing its rate of degradation and promoting its rate of synthesis by the kidney.
